BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25634)

  • 1. Inhibition of experimental immediate hypersensitivity reactions by a novel xanthone, RU 31156.
    Miller P; James GW
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):328-39. PubMed ID: 25634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R; Kazimierczak W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
    Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
    J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
    Spicer BA; Ross JW; Smith H
    Clin Exp Immunol; 1975 Sep; 21(3):419-29. PubMed ID: 812623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo anti-allergic and bronchopulmonary pharmacology of REV 3164 in rats and guinea-pigs.
    Leibowitz M; Gordon RJ; Wolf PS; Sonnino-Goldman P
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):135-54. PubMed ID: 6497506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
    Evans DP; Thomson DS
    Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
    Casey FB; Abboa-Offei BE; Marretta J
    J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hypersensitivity reactions by 16(S)-methyl-20-methoxy-PGE2 (YPG-209) in animals.
    Tomioka K; Maeno H
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):157-65. PubMed ID: 6251764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
    Terasawa M; Goto K; Maruyama Y
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of predosing with Y-12,141 on its antiallergic activity. --Studies on anti-allergic agents(IV)-- (author's transl)].
    Goto K; Terasawa M; Komori A; Maruyama Y
    Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):123-9. PubMed ID: 6786963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
    De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
    Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BL-5255. I. Activity in animal models of immediate hypersensitivity reactions.
    Siminoff P; Reed FC; Schurig JE
    Int Arch Allergy Appl Immunol; 1982; 67(2):101-8. PubMed ID: 6799411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
    Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
    Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.
    Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M
    Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.